David B. Agus
- Oncology top 1%
- HER2/EGFR in Cancer Research 15
- Cancer Treatment and Pharmacology 12
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 10
- Cancer, Lipids, and Metabolism 10
-
- Prostate Cancer Treatment and Research 52
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways 9
- Spectroscopy top 1%
- Advanced Proteomics Techniques and Applications 9
-
- Radiopharmaceutical Chemistry and Applications 14
David B. Agus
115 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Oncology 2.2k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 1.9k
- Molecular Biology 3.9k
- Spectroscopy 765
Countries citing papers authored by David B. Agus
This map shows the geographic impact of David B. Agus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Agus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Agus more than expected).
Fields of papers citing papers by David B. Agus
This network shows the impact of papers produced by David B. Agus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Agus. The network helps show where David B. Agus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David B. Agus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2022 | 3 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 42 | |
| 5 | 2017 | 18 | |
| 6 | 2016 | 49 | |
| 7 | The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells | 2015 | 7 |
| 8 | 2015 | 59 | |
| 9 | 2014 | 34 | |
| 10 | 2012 | 6 | |
| 11 | 2010 | 72 | |
| 12 | 2010 | 56 | |
| 13 | 2009 | 98 | |
| 14 | 2008 | 39 | |
| 15 | 2005 | 37 | |
| 16 | HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer. | 2001 | 130 |
| 17 | A potential role for activated HER-2 in prostate cancer. | 2000 | 36 |
| 18 | Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. | 1999 | 123 |
| 19 | Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal. | 1998 | 50 |
| 20 | 1991 | 232 |
About David B. Agus
David B. Agus is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 116 papers that have together received 8.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (52 papers), HER2/EGFR in Cancer Research (15 papers), Radiopharmaceutical Chemistry and Applications (14 papers), Cancer Treatment and Pharmacology (12 papers), Cancer Genomics and Diagnostics (10 papers), Cancer, Lipids, and Metabolism (10 papers), Ubiquitin and proteasome pathways (9 papers) and Advanced Proteomics Techniques and Applications (9 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (1.0k citations) and Pulmonary and Respiratory Medicine (1.9k citations). David B. Agus has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Parag Mallick, Darren Kessner, Robert Burke, Matt Chambers, Howard I. Scher, Carlos Cordon‐Cardo, Brian Higgins, Mitchell E. Gross, David W. Golde and Marija Drobnjak. Their work appears in journals such as Journal of Clinical Oncology, The Prostate, Scientific Reports, Clinical Cancer Research and Psycho-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.